secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sana Biotechnology, Inc. (SANA)
CIK:        0001770121
Form:       8-K
Filed at:   2023-08-21T23:59:59+00:00
Accession:  0000950170-23-043683
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Sana Biotechnology terminates Fremont lease for $3.42M; moves manufacturing to Bothell, WA
--------------------------------------------------------------------------------

- Lease for 163,193 sq ft in Fremont, CA terminated Aug 30, 2023.
- Termination fee of approximately $3.42 million paid to landlord.
- Irrevocable letter of credit returned; mutual release of claims with customary exclusions.
- Company will establish its planned manufacturing facility at Bothell Facility (79,565 sq ft) instead.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1770121/000095017023043683/0000950170-23-043683-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1770121/000095017023043683/sana-20230817.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-043683

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer